Back to User profile » Dr Yuhei Sangatsuda
Paper published by Dr Yuhei Sangatsuda:
Original Research
Add-on bevacizumab can prevent early clinical deterioration and prolong survival in newly diagnosed partially resected glioblastoma patients with a poor performance status
Hata N, Yoshimoto K, Hatae R, Kuga D, Akagi Y, Sangatsuda Y, Suzuki SO, Shono T, Mizoguchi M, Iihara K
OncoTargets and Therapy 2017, 10:429-437
Published Date: 18 January 2017